Part I Re-thinking Depression from a Network Perspective
1. Phenotype Network and Brain Structural Covariance Network of Major Depression - page 3
2. Task MRI-Based Functional Brain Network of Major Depression - page 19
3. White Matter-Based Structural Brain Network of Major Depression - page 35
4. The Application of a Machine Learning-Based Brain MRI Approach in Major Depression - page 57
5. Common Currency Between Experience and Brain Spatiotemporal Psychopathology of the Resting State in Depression - page 71
6. Development of Neuroimaging-Based Biomarkers in Major Depression - page 85
Part II Current Diagnostic and Neurobiological Issues
7. Challenges and Strategies for Current Classifications of Depressive Disorders Proposal for Future Diagnostic Standards - page 103
8. Epigenetics A Missing Link Between Early Life Stress and Depression - page 117
9. From Leaky Gut to Impaired Glia-Neuron Communication in Depression - page 129
10. Neurogenesis and Neuroplasticity in Major Depression Its Therapeutic Implication - page 157
11. A Load to Find Clinically Useful Biomarkers for Depression - page 175
12. Genetic Architecture of Depression Where Do We Stand Now - page 203
13. Pharmacogenetic Pharmacogenomic Tests for Treatment Prediction in Depression - page 231
14. The Role of Neurotrophic Factors in Pathophysiology of Major Depressive Disorder - page 257
Part III Current Specific Treatments for Depression
15. Clinical Application of Real-Time fMRI-Based Neurofeedback for Depression - page 275
16. Cognitive Behavioral Therapy and Mindfulness-Based Cognitive Therapy for Depressive Disorders - page 295
17. Acceptance and Commitment Therapy for Major Depressive Disorder Insights into a New Generation of Face-to-Face Treatment and Digital Self-Help Approaches - page 311
18. Current Updates on Newer Forms of Transcranial Magnetic Stimulation in Major Depression - page 333
19. Well-being Therapy in Depressive Disorders - page 351
20. Current Research on Complementary and Alternative Medicine CAM in the Treatment of Major Depressive Disorder An Evidence-Based Review - page 375
21. Psychopharmacology Algorithms for Major Depressive Disorder Current Status - page 429
Part IV Promising Future Treatments for Depression
22. Novel Psychopharmacology for Depressive Disorders - page 449
23. Creative Person-Centered Narrative Psychopharmacotherapy of Depression - page 463
24. Induced Pluripotent Stem Cells iPSCs Technology Potential Targets for Depression - page 493
25. Vaccination and Immunotherapy for Major Depression - page 503
26. Psychedelic Medicines in Major Depression Progress and Future Challenges - page 515
27. Precision Psychiatry Biomarker-Guided Tailored Therapy for Effective Treatment and Prevention in Major Depression - page 535